Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Isotopia Issues a call to action to the radionuclide Therapy industry. 2023-09-06 20:40
Teikoku Pharma USA announces positive topline results from Phase 2 clinical trial of TPU-006, non- opioid pain management patch in Abdominoplasty Surgery. 2023-09-06 20:06
Gloria Biosciences Announces Zimberelimab Approved in China for the Treatment of Recurrent or Metastatic Cervical Cancer 2023-09-06 19:00
Brii Biosciences Announces Topline Interim Results of Phase 2 Study Evaluating BRII-179 (VBI-2601) in Combination with PEG-IFNα for the Treatment of Chronic Hepatitis B 2023-09-06 18:45
CANbridge to Participate in Two Investor Conferences in September 2023-09-06 16:06
Telix to Showcase New ZIRCON Phase III Kidney Cancer Imaging Data and Theranostic Pipeline at EANM 2023-09-06 14:18
MedAlliance announces enrollment of First Patient in SELUTION SLR LOVE-DEB Coronary Study 2023-09-06 08:00
MALAYSIA HEALTHCARE TRAVEL COUNCIL SELECTS MAYO CLINIC TO PROVIDE STRATEGIC COUNSEL TO FURTHER ADVANCE MEDICAL EXCELLENCE IN MALAYSIA 2023-09-05 22:37
YS Biopharma to Participate in Citi's 18th Annual Biopharma Conference 2023-09-05 20:30
Alteogen's Tergase® (Novel Recombinant Human Hyaluronidase Injection) Shows Excellent Immunogenicity Profile 2023-09-05 20:00
I-Mab Announces Upcoming Participation at September Conferences 2023-09-05 20:00
ACM Biolabs Announces Positive Topline Results from a Phase I Trial of SARS-CoV-2 Booster Vaccine ACM-001 2023-09-05 14:00
GCCL to be the first in the industry sector to adopt Lab Information Management System (LIMS) 2023-09-05 09:57
Seegene Unveils 'Open Innovation Program Powered by Seegene' in Partnership with Springer Nature 2023-09-04 21:00
National University Health System Launches World's First Public Hospital's Healthy Longevity Clinic at Alexandra Hospital 2023-09-02 13:00
ABM Therapeutics Announces First Patient Dosed in Phase I Study of ABM-1310 in patients with BRAF V600 in Relapsed and Drug Resistant Primary Malignant Brain Tumors 2023-09-02 00:00
Adicon Holdings Limited (9860.HK): Continuous growth in Core Operations, Consistent Profitability Enhancement 2023-09-01 21:30
CANbridge Announces Interim Financial Results and Corporate Updates for the Six Months Ended June 30, 2023 2023-08-31 15:15
Tycoon Group Announces 2023 Interim Results 2023-08-31 13:28
Sirnaomics Announces Successful Phase I Clinical Study of RNAi Therapeutic STP707 for Treatment of Multiple Solid Tumors 2023-08-31 11:30
1 92 93 94 95 96 423